These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34317572)

  • 1. Lead Macrodislodgement of a Subcutaneous Implantable Cardioverter-Defibrillator Results in a Reel Problem.
    El-Zein RS; Shah A; Luli J; Stelzer M; Fu E; Amin AK
    JACC Case Rep; 2021 Mar; 3(3):523-527. PubMed ID: 34317572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.
    Viani S; Migliore F; Tola G; Pisanò ECL; Russo AD; Luzzi G; Sartori P; Piro A; Rordorf R; Forleo GB; Rago A; Segreti L; Bertaglia E; Biffi M; Lovecchio M; Valsecchi S; Diemberger I; Bongiorni MG
    Heart Rhythm; 2019 Apr; 16(4):564-571. PubMed ID: 30366163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous Implantable Cardioverter Defibrillator Lead Failure due to Twiddler Syndrome.
    Kooiman KM; Brouwer TF; Van Halm VP; Knops RE
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1369-71. PubMed ID: 26306701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reel Syndrome: An Atypical Cause for Inappropriate Shocks in a Patient with Automated Implantable Cardioverter Defibrillator (AICD).
    Mohammad R; Pervaiz A; Mufti M; Khan K; Syed S; Prabhu S
    Cureus; 2018 Feb; 10(2):e2237. PubMed ID: 30949420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey.
    Boveda S; Lenarczyk R; Fumagalli S; Tilz R; Goscinska-Bis K; Kempa M; Defaye P; Marquié C; Capucci A; Ueberham L; Dagres N
    Europace; 2018 May; 20(5):887-892. PubMed ID: 29432525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review.
    Pagore PA; Gaidhane SA
    Cureus; 2022 Oct; 14(10):e30170. PubMed ID: 36397900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous implantable cardioverter defibrillator after transvenous lead extraction: safety, efficacy and outcome.
    Giacomin E; Falzone PV; Dall'Aglio PB; Pittorru R; De Lazzari M; Vianello R; Bertaglia E; Tarzia V; Iliceto S; Gerosa G; Migliore F
    J Interv Card Electrophysiol; 2022 Jul; ():. PubMed ID: 35831772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient characteristics and in-hospital complications of subcutaneous implantable cardioverter-defibrillator for Brugada syndrome in Japan.
    Kawamura I; Nakajima M; Kitamura T; Kaszynski RH; Hojo R; Ohbe H; Sasabuchi Y; Matsui H; Fushimi K; Fukamizu S; Yasunaga H
    J Arrhythm; 2019 Dec; 35(6):842-847. PubMed ID: 31844476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
    Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
    Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in electrogram interpretation: Subcutaneous cardioverter defibrillator malfunction in Brugada syndrome.
    Morani G; Bolzan B; Tomasi L; Tomei R; Vassanelli C
    Pacing Clin Electrophysiol; 2017 Oct; 40(10):1180-1183. PubMed ID: 28432805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5A.
    Yokoyama Y; Aiba T; Ueda N; Nakajima K; Kamakura T; Wada M; Yamagata K; Ishibashi K; Inoue Y; Miyamoto K; Nagase S; Noda T; Yasuda S; Shimizu W; Kusano K
    J Cardiol Cases; 2020 Nov; 22(5):238-241. PubMed ID: 33133318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Subcutaneous Defibrillator Implantation in a Pregnant Patient With Long QT Syndrome.
    Myadam R; Gupta SK
    JACC Case Rep; 2021 Mar; 3(3):504-507. PubMed ID: 34317568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized Trial.
    Leong DP; Dokainish H; Mondésert B; Cavalli G; Khetan A; Cirne F; Baro Vila R; Klimis H; De Jesus TA; AlGhasab NS; Akbari V; Suliman A; Eltebi O; Almhri A; Ferdous T; Djuric A; Bashir J; Krahn AD; Exner DV; Philippon F; Birne DH; Joza J; Healey JS
    JACC Clin Electrophysiol; 2024 Jun; ():. PubMed ID: 39001765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.